In addition, high Gal-1 levels in blood from PDA patients suggest that it could be a useful marker for patient follow-up—e.g., for detecting recurrence after surgery and for evaluating tumor response during chemotherapy or chemo/radiotherapy, as reported for other tumor types [33, 34]. Here, LGALS1 is linked to neoplasm.